- Home
- NEO vs EVT Comparison
NEO vs EVT Comparison
Compare NEO & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- EVT
- Stock Information
- Founded
- NEO 2001
- EVT 2003
- Country
- NEO United States
- EVT United States
- Employees
- NEO N/A
- EVT N/A
- Industry
- NEO Precision Instruments
- EVT Finance Companies
- Sector
- NEO Health Care
- EVT Finance
- Exchange
- NEO Nasdaq
- EVT Nasdaq
- Market Cap
- NEO 2.1B
- EVT 1.8B
- IPO Year
- NEO 1999
- EVT N/A
- Fundamental
- Price
- NEO $13.50
- EVT $24.68
- Analyst Decision
- NEO Strong Buy
- EVT
- Analyst Count
- NEO 9
- EVT 0
- Target Price
- NEO $19.89
- EVT N/A
- AVG Volume (30 Days)
- NEO 917.6K
- EVT 121.5K
- Earning Date
- NEO 11-05-2024
- EVT 01-01-0001
- Dividend Yield
- NEO N/A
- EVT 7.72%
- EPS Growth
- NEO N/A
- EVT N/A
- EPS
- NEO N/A
- EVT N/A
- Revenue
- NEO $628,248,000.00
- EVT N/A
- Revenue This Year
- NEO $12.95
- EVT N/A
- Revenue Next Year
- NEO $9.49
- EVT N/A
- P/E Ratio
- NEO N/A
- EVT N/A
- Revenue Growth
- NEO 13.89
- EVT N/A
- 52 Week Low
- NEO $12.77
- EVT $18.70
- 52 Week High
- NEO $21.22
- EVT $23.82
- Technical
- Relative Strength Index (RSI)
- NEO 37.91
- EVT 57.87
- Support Level
- NEO $12.77
- EVT $24.57
- Resistance Level
- NEO $14.19
- EVT $24.81
- Average True Range (ATR)
- NEO 0.60
- EVT 0.26
- MACD
- NEO 0.01
- EVT 0.01
- Stochastic Oscillator
- NEO 31.60
- EVT 67.50
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.